4.2 Article

Brain morphological abnormalities in children with cyclin-dependent kinase-like 5 deficiency disorder

Journal

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
Volume 31, Issue -, Pages 46-53

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejpn.2021.02.004

Keywords

CDKL5 deficiency disorder (CDD); Epileptic encephalopathy; Children; Magnetic resonance imaging (MRI); Surface-based analysis

Funding

  1. National Institutes of Health (NIH) [R01 NS109439]

Ask authors/readers for more resources

Quantitative MRI analysis of children with CDD revealed global volume loss in the cortex and subcortical gray matter, showing a progressive trend with disease progression. Cortical thickness proved to be a more sensitive measure than surface area in disclosing cortical atrophy and disease progression.
Background: To quantitatively evaluate the brain MRI morphological abnormalities in patients with cyclin-dependent kinase-like 5 deficiency disorder (CDD) on a group level and longitudinally. Methods: We performed surface-based MRI analysis on high-resolution T1-weighted images on three CDD patients scanned at age of three years, and compared with 12 age-and gender-matched healthy controls. We further examined the longitudinal morphological changes in one patient with a follow-up of 5 years. Results: CDD patients presented significant reductions in total intracranial volume, total gray matter (GM) volume and subcortical GM volume compared to controls. For subcortical regions, significant GM volume reductions were seen in the brain stem, bilateral thalamus, bilateral hippocampus, bilateral cerebellum and left amygdala. Although GM volume of cortical mantle did not show statistical differences overall, significant reduction was detected in bilateral parietal, left occipital and right temporal lobes. Cortical thickness exhibited significant decreases in bilateral occipital, parietal and temporal lobes, while surface area did not show any significant differences. Longitudinal follow-up in one patient revealed a monotonic downward trend of relative volume in the majority of brain regions. The relative surface area appeared to gain age-related growth, whereas the relative cortical thickness exhibited a striking progressive decline over time. Conclusions: Quantitative morphology analysis in children with CDD showed global volume loss in the cortex and more notably in the subcortical gray matter, with a progressive trend along with the disease course. Cortical thickness is a more sensitive measure to disclose cortical atrophy and disease progression than surface area. (c) 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Clinical Neurology

Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis

Arthur Stefanski, Yamile Calle-Lopez, Costin Leu, Eduardo Perez-Palma, Elia Pestana-Knight, Dennis Lal

Summary: This meta-analysis and systematic review examined the diagnostic yield of clinical sequencing studies in individuals with neurodevelopmental disorders, finding differences in success rates across NDD subtypes and sequencing technologies. Studies were predominantly conducted in countries with a high Inequality-adjusted Human Development Index, with potential barriers to genetic testing in regions like Africa, India, and Latin America.

EPILEPSIA (2021)

Article Pediatrics

Treatment Practices and Outcomes in Continuous Spike and Wave during Slow Wave Sleep: A Multicenter Collaboration

Fiona M. Baumer, Nancy A. McNamara, Anthony L. Fine, Elia Pestana-Knight, Renee A. Shellhaas, Zihuai He, Daniel H. Arndt, William D. Gaillard, Sarah A. Kelley, Margot Nagan, Adam P. Ostendorf, Nilika S. Singhal, Laura Speltz, Kevin E. Chapman

Summary: In the US, benzodiazepines and antiseizure medications are the most common initial therapies prescribed for CSWS, but the study suggests that benzodiazepines and steroids are more effective than antiseizure medications. Treatment choice does not depend on baseline clinical variables, nor correlate with outcomes.

JOURNAL OF PEDIATRICS (2021)

Article Clinical Neurology

Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder

Jacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, Eric D. Marsh, Bernhard Suter, Rajsekar Rajaraman, Gena Heidary, Heather E. Olson, Orrin Devinsky, Dana Price, Peter Jacoby, Helen Leonard, Tim A. Benke, Scott Demarest, Jenny Downs

Summary: The content of the clinician-reported items in CCSA (CCSA-Clinician) was validated through interviews and consensus meetings with neurologists from the USA CDD Center of Excellence clinics. Eight original items were omitted, 11 items were added, and the remaining 18 items were revised. The final 29 items were classified into 2 domains: functioning and neurologic impairments, providing evidence for the content validity of CCSA-Clinician.

JOURNAL OF CHILD NEUROLOGY (2021)

Article Clinical Neurology

Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder

Heather E. Olson, Carolyn Daniels, Isabel Haviland, Lindsay C. Swanson, Caitlin A. Greene, Anne Marie M. Denny, Scott T. Demarest, Elia Pestana-Knight, Xiaoming Zhang, Ahsan N. Moosa, Andrea Fidell, Judith L. Weisenberg, Bernhard Suter, Cary Fu, Jeffrey L. Neul, Alan K. Percy, Eric D. Marsh, Timothy A. Benke, Annapurna Poduri

Summary: The treatment for neurological features of CDD is currently symptom-based and empirical, not specific to CDD. Anti-seizure medications are commonly used, with ketogenic diet also being a common treatment approach. There is limited information on medications for sleep, behavioral management, and movement disorders, highlighting the need for further research in these areas.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2021)

Article Clinical Neurology

Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder

Helen Leonard, Mohammed Junaid, Kingsley Wong, Alex A. Aimetti, Elia Pestana Knight, Jenny Downs

Summary: This study found that patients with better early seizure control showed slightly improved development later, suggesting that an individual child's trajectory is not necessarily predetermined and could possibly be influenced by optimal seizure management. This has implications for children's quality of life.

EPILEPSIA (2022)

Article Clinical Neurology

Surgical candidates in children with epileptic spasms can be selected without invasive monitoring: A report of 70 cases

Gozde Erdemir, Elia Pestana-Knight, Ryan Honomichl, Nicolas R. Thompson, Deepak Lachhwani, Prakash Kotagal, Elaine Wyllie, Ajay Gupta, William E. Bingaman, Ahsan N. Moosa

Summary: Surgery for drug-resistant epileptic spasms in children without intracranial EEG monitoring can achieve favorable outcomes, especially when epileptogenic lesions are identified on MRI. These findings suggest that surgery can be considered as a treatment option without the need for invasive monitoring in selected pediatric patients.

EPILEPSY RESEARCH (2021)

Review Clinical Neurology

CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment

William Hong, Isabel Haviland, Elia Pestana-Knight, Judith L. Weisenberg, Scott Demarest, Eric D. Marsh, Heather E. Olson

Summary: Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a developmental and epileptic encephalopathy with infantile-onset epilepsy. The management of seizures in CDD is challenging due to their highly refractory nature and limited evidence-based treatment options.

CNS DRUGS (2022)

Editorial Material Clinical Neurology

Hypsarrhythmia and Epileptic Spasms: A Look at One Old Epilepsy in the Modern Era

Elia M. Pestana Knight

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2022)

Review Clinical Neurology

Historical Overview of Hypsarrhythmia and Its Association to Epileptic Spasms: A Review of the Medical Literature From 1952 to 1982

Elia M. Pestana Knight, Jayanti Mani

Summary: This article provides a historical review of knowledge developments about hypsarrhythmia and infantile spasms, with a focus on the period from 1952 to 1982. The goal is to highlight clinical elements that were discovered during that time and remain clinically relevant today.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2022)

Article Clinical Neurology

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder

Sam Amin, Marie Monaghan, Angel Aledo-Serrano, Nadia Bahi-Buisson, Richard F. Chin, Angus J. Clarke, J. Helen Cross, Scott Demarest, Orrin Devinsky, Jenny Downs, Elia M. Pestana Knight, Heather Olson, Carol-Anne Partridge, Graham Stuart, Marina Trivisano, Sameer Zuberi, Tim A. Benke

Summary: This article presents the characteristics, incidence, and impact of CDKL5 Deficiency Disorder (CDD), as well as recommendations from international healthcare professionals to address the diverse needs of individuals with CDD. Using a Delphi method, a consensus was reached and clinical management recommendations were proposed. These recommendations aim to standardize and improve the medical care for individuals with CDD.

FRONTIERS IN NEUROLOGY (2022)

Article Pediatrics

Continuous electroencephalography (cEEG) in infants with congenital heart disease (CHD)

Swetha Padiyar, Neil Friedman, Elia Pestana-Knight, Ahsan Mossa-Naduvil, Linda Franic, Sarah Worley, Hany Aly

Summary: This study investigates the pre- and post-operative continuous EEG patterns in neonates with congenital heart disease, aiming to detect abnormal cerebral activity and explore the association between encephalopathy severity before and after surgery.

PEDIATRIC RESEARCH (2023)

Article Clinical Neurology

Temporal Seizure Emerging From a Cluster of Eyelid Myoclonia in a Teenager With Jeavon Syndrome

Ifrah Zawar, Linda Franic, Elia Pestana Knight

NEUROLOGY-CLINICAL PRACTICE (2021)

Article Clinical Neurology

The Efficacy and Use of a Pocket Card Algorithm in Status Epilepticus Treatment

Jessica R. Fesler, Anne E. Belcher, Ahsan N. Moosa, MaryAnn Mays, Lara E. Jehi, Elia M. Pestana Knight, Deepak K. Lachhwani, Andreas Alexopoulos, Dileep R. Nair, Vineet Punia

Summary: The study found that a pocket card is a beneficial educational tool for improving the implementation of treatment guidelines for status epilepticus. Teams with access to the pocket card had a shorter time to rescue therapy, while the presence of the card did not significantly impact the dosing adequacy. At the 9-month follow-up, most participants self-reported having the pocket card, but only a small portion could confirm the identification number.

NEUROLOGY-CLINICAL PRACTICE (2021)

Article Clinical Neurology

Characterizing the phenotype of drug-resistant childhood epilepsy associated with leukemia: A case series

Elham Abushanab, Elia Pestana Knight, Ahsan N. Moosa

Summary: Children with a history of leukemia are at risk for drug-resistant epilepsy, with phenotypes including Lennox-Gastaut syndrome and focal epilepsy. Some patients show structural abnormalities on brain MRI, potentially contributing to the development of epilepsy.

EPILEPSY & BEHAVIOR REPORTS (2021)

Article Clinical Neurology

Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study

Karlijn Bouman, Jeroen L. M. van Doorn, Jan T. Groothuis, Peter J. Wijkstra, Baziel G. M. van Engelen, Corrie E. Erasmus, Jonne Doorduin, Nicol C. Voermans

Summary: The majority of LAMA2-MD and all SELENON-RM patients had respiratory impairment. SELENON-RM patients showed lower respiratory function which was progressive, more prevalent mechanical ventilation, and more severe diaphragm atrophy and dysfunction than LAMA2-MD patients. Spirometry (FVC%, dVC) and respiratory muscle strength tests (SNIP) are useful in clinical care and as outcome measure in clinical trials.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2024)

Article Clinical Neurology

An online survey among general pediatricians on melatonin use in children with chronic insomnia

Oliviero Bruni, Maria Breda, Emanuela Malorgio, Paolo Brambilla, Flavia Ceschin, Andrea Di Pilla, Maurizio Elia, Raffaele Ferri

Summary: This study aimed to describe the use of melatonin by Italian pediatricians in healthy children with chronic insomnia. The results showed that a high percentage of pediatricians prescribed melatonin, especially in children aged 1-2 years. The most common dosage was 1 mg/day and it was usually recommended to be taken 30 minutes before bedtime. Melatonin was often combined with sleep hygiene and was found to be effective in reducing difficulties falling asleep.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2024)

Article Clinical Neurology

Yield of exome sequencing in patients with developmental and epileptic encephalopathies and inconclusive targeted gene panel

Lucie Sedlackova, Katalin Sterbova, Marketa Vlckova, Pavel Seeman, Jana Zarubova, Petr Marusic, Pavel Krsek, Hana Krijtova, Alena Musilova, Petra Lassuthova

Summary: In this study, whole exome sequencing (WES) was performed to identify causal variants for developmental and epileptic encephalopathies (DEEs) in patients whose genetic diagnosis was not determined by gene panel testing. The results showed that WES can successfully identify disease-causing variants, even after inconclusive gene panel testing. Detailed clinical evaluations and phenotype-genotype correlation studies were conducted to better understand the rare subtypes of DEEs.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2024)